14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
REPX vs GRNT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Riley Exploration Permian, Inc. (REPX) is the stronger overall head-to-head candidate over Granite Ridge Resources, Inc. (GRNT) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). REPX carries a Unified Composite Score of 76.5/100 (STRONG BUY) at $41.04 (3.4x Forward P/E, 45.7% operating margin), whereas GRNT carries 47.1/100 (HOLD) at $5.49 (5.6x Forward P/E, 4.8% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on REPX vs GRNT. Trailing 12-month operating profitability (REPX 45.7% vs GRNT 4.8%) and valuation multiples (REPX 3.4x vs GRNT 5.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Oil & Gas E&P value chain with $741.6M market capitalization and 4.8% operating margin.
OpEx & R&D Reinvestment72.3% of Rev ($386M)
90D Engineering Disclosures0 Published
Investor FAQ REPX vs GRNT Key Questions & Quantitative Answers
As of Nov 20, 2026, Riley Exploration Permian, Inc. (REPX) is the stronger overall head-to-head candidate over Granite Ridge Resources, Inc. (GRNT) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). REPX carries a Unified Composite Score of 76.5/100 (STRONG BUY) at $41.04 (3.4x Forward P/E, 45.7% operating margin), whereas GRNT carries 47.1/100 (HOLD) at $5.49 (5.6x Forward P/E, 4.8% operating margin). Technically, REPX sits in a Neutral phase (RSI 39.3, UNCLASSIFIED options structure) and GRNT sits in a Neutral phase (RSI 48.0, UNCLASSIFIED options structure).
REPX leads the Growth & Scale pillar: REPX posts +88.3% YoY revenue growth and +185.4% YoY earnings growth on $578M TTM revenue (73.7% gross margin, 45.7% operating margin), compared with GRNT at +57.5% YoY revenue growth and +19.7% YoY earnings growth on $534M TTM revenue (77.1% gross margin, 4.8% operating margin). On trailing 12-month operating scale, REPX generates $578M in USD-normalized revenue versus $534M for GRNT. In operating R&D and SG&A reinvestment, REPX deploys 28.0% of Rev ($162M) (0 90-day corporate R&D disclosures) versus 72.3% of Rev ($386M) (0 disclosures) for GRNT.
REPX screens cheaper on headline valuation multiples. REPX trades at 3.4x Forward P/E, 8.7x Trailing P/E, 2.84x PEG, and 1.6x EV/Revenue (64.9% EBITDA margin), whereas GRNT trades at 5.6x Forward P/E, 8.2x Trailing P/E, N/M PEG, and 1.4x EV/Revenue (51.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against REPX (16.8% ROE) versus GRNT (-8.8% ROE) capital efficiency.
In options market volatility and institutional positioning, REPX carries 74.5% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.65β · 62% Vol realized risk). By comparison, GRNT carries 54.1% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.54β · 80% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.